JW Therapeutics Company
JW Therapeutics is a developer of cell-based therapy technologies created to revolutionize cancer treatment.
.jpeg)
Technology:
CAR-T
Industry:
Public
Headquarters:
Shanghai, Shanghai, China
Founded Date:
2016-02-01
Employees Number:
51-100
Funding Status:
IPO
Investors Number:
14
Total Funding:
190000000
Estimated Revenue:
$1M to $10M
Last Funding Date:
2020-06-11
Last Funding Type:
Series B
Register and Claim Ownership